Reilly John P, Anderson Brian J, Mangalmurti Nilam S, Nguyen Tam D, Holena Daniel N, Wu Qufei, Nguyen Ethan T, Reilly Muredach P, Lanken Paul N, Christie Jason D, Meyer Nuala J, Shashaty Michael G S
Divisions of Pulmonary, Allergy, and Critical Care and
Divisions of Pulmonary, Allergy, and Critical Care and.
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1911-20. doi: 10.2215/CJN.12201214. Epub 2015 Sep 4.
ABO blood types are determined by antigen modifications on glycoproteins and glycolipids and associated with altered plasma levels of inflammatory and endothelial injury markers implicated in AKI pathogenesis. We sought to determine the association of ABO blood types with AKI risk in critically ill patients with trauma or sepsis.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two prospective cohort studies at an urban, academic, level I trauma center and tertiary referral center; 497 patients with trauma admitted to the surgical intensive care unit between 2005 and 2010 with an injury severity score >15 and 759 patients with severe sepsis admitted to the medical intensive care unit between 2008 and 2013 were followed for 6 days for the development of incident AKI. AKI was defined by Acute Kidney Injury Network creatinine and dialysis criteria.
Of 497 patients with trauma, 134 developed AKI (27%). In multivariable analysis, blood type A was associated with higher AKI risk relative to type O among patients of European descent (n=229; adjusted risk, 0.28 versus 0.14; risk difference, 0.14; 95% confidence interval, 0.03 to 0.24; P=0.02). Of 759 patients with sepsis, AKI developed in 326 (43%). Blood type A again conferred higher AKI risk relative to type O among patients of European descent (n=437; adjusted risk, 0.53 versus 0.40; risk difference, 0.14; 95% confidence interval, 0.04 to 0.23; P=0.01). Findings were similar when analysis was restricted to those patients who did not develop acute respiratory distress syndrome or were not transfused. We did not detect a significant association between blood type and AKI risk among individuals of African descent in either cohort.
Blood type A is independently associated with AKI risk in critically ill patients with trauma or severe sepsis of European descent, suggesting a role for ABO glycans in AKI susceptibility.
ABO血型由糖蛋白和糖脂上的抗原修饰决定,并与急性肾损伤(AKI)发病机制中涉及的炎症和内皮损伤标志物的血浆水平改变相关。我们试图确定ABO血型与创伤或脓毒症重症患者发生AKI风险之间的关联。
设计、地点、参与者及测量方法:我们在一家城市学术I级创伤中心和三级转诊中心进行了两项前瞻性队列研究;对2005年至2010年间入住外科重症监护病房、损伤严重程度评分>15的497例创伤患者,以及2008年至2013年间入住内科重症监护病房的759例严重脓毒症患者进行了为期6天的随访,观察新发AKI的发生情况。AKI根据急性肾损伤网络肌酐和透析标准进行定义。
497例创伤患者中,134例发生AKI(27%)。在多变量分析中,在欧洲血统患者(n=229)中,A型血患者发生AKI的风险相对于O型血更高(校正风险,0.28对0.14;风险差异,0.14;95%置信区间,0.03至0.24;P=0.02)。759例脓毒症患者中,326例(43%)发生AKI。在欧洲血统患者(n=437)中,A型血患者发生AKI的风险再次高于O型血患者(校正风险,0.53对0.40;风险差异,0.14;95%置信区间,0.04至0.23;P=0.01)。当分析仅限于未发生急性呼吸窘迫综合征或未接受输血的患者时,结果相似。在两个队列中,我们均未检测到非洲血统个体的血型与AKI风险之间存在显著关联。
在欧洲血统创伤或严重脓毒症重症患者中,A型血与AKI风险独立相关,提示ABO聚糖在AKI易感性中起作用。